Xuemei Li

2.3k citations
37 papers · 1.8k indexed · 1 hit paper · h-index 14
Topics
Circular RNAs in diseases (10 papers)MicroRNA in disease regulation (9 papers)Cancer-related molecular mechanisms research (8 papers)

In The Last Decade

Xuemei Li

35 papers receiving 1.8k citations

Hit Papers

Identification of ACSL4 as a biomarker and contributor of...20162026201920222016250500750

Peers

Xuemei Li
Comparison fields: 5 of 98
  • Molecular Biology 1.1k
  • Cancer Research 792
  • Pulmonary and Respiratory Medicine 687
  • Plant Science 307
  • Epidemiology 155
Replace Yulu Zhou with:
Yulu Zhou China
Yanli Guo China
Yvette Habraken Belgium
Meiying Luo China
Fang Su China
Jianguo Huang China
Lei Cao China
Fan Deng China
Wei Zhai China
Hsi‐Yuan Huang Taiwan
Xuemei Li relative to Yulu Zhou China Yulu Zhou's profile →
Citations per field
00.5×1.5×2.0×
Yulu Zhou · 1×
Citations per year

Countries citing papers authored by Xuemei Li

Since Specialization
Citations

This map shows the geographic impact of Xuemei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Li more than expected).

Fields of papers citing papers by Xuemei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Li. The network helps show where Xuemei Li may publish in the future.

Co-authorship network of co-authors of Xuemei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Li. A scholar is included among the top collaborators of Xuemei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Li. Xuemei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 10
5 4
6 2
7 6
8 4
9 13
10 6
11 8
12 58
13 20
14 53
15
Identification of ACSL4 as a biomarker and contributor of ferroptosisbreakdown →
831
16 45
17 45
18 147
19 41
20 255

About Xuemei Li

Xuemei Li is a scholar working on Cancer Research, Aging and Physiology, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Circular RNAs in diseases (10 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (792 citations), Pulmonary and Respiratory Medicine (687 citations) and Molecular Biology (1.1k citations). Xuemei Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hua Yuan, Daolin Tang, Rui Kang, Xiuying Zhang, Zihai Li, Kezhong Zhang, Wolf‐Dieter Reiter, Jeffrey L. Caplan, Gary Vanzin and Nicholas C. Carpita. Their work appears in journals such as The Plant Cell, PLANT PHYSIOLOGY and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026